Tazidime and Colitis ischaemic - a phase IV clinical study of FDA data

Summary:

Colitis ischaemic is reported as a side effect among people who take Tazidime (ceftazidime), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Metronidazole, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Colitis ischaemic when taking Tazidime. It is created by eHealthMe based on reports of 10,389 people who have side effects when taking Tazidime from the FDA, and is updated regularly.

What is Tazidime?

Tazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,409 Tazidime users. Check the latest studies of Tazidime.

What is Colitis ischaemic?

Colitis ischaemic (due to infection of intestine impaired blood supply to colon) is found to be associated with 800 drugs and 835 conditions by eHealthMe. Check the latest studies of Colitis ischaemic.

On Jul, 29, 2026

10,389 people reported to have side effects when taking Tazidime.
Among them, 18 people (0.17%) have Colitis ischaemic.

Among these 18 people:

How long have people been on Tazidime when they have Colitis ischaemic? *

What is the gender of people who have Colitis ischaemic when taking Tazidime? *

female: 18.75 %
male: 81.25 %

What is the age of people who have Colitis ischaemic when taking Tazidime? *

What are other drugs people take besides Tazidime? *

Metronidazole: 16 people, 88.89%
Nystatin: 14 people, 77.78%
Vancomycin: 14 people, 77.78%
Fluconazole: 13 people, 72.22%
Gentamicin: 12 people, 66.67%
Piperacillin And Tazobactam: 7 people, 38.89%
Voriconazole: 4 people, 22.22%
Gentamicin Sulfate: 2 people, 11.11%
Fluocinolone Acetonide: 1 person, 5.56%
Folic Acid: 1 person, 5.56%

What are other side effects people have besides Colitis ischaemic? *

Septic Shock (shock due to blood infection): 14 people, 77.78%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 14 people, 77.78%
Fungal Peritonitis (fungal infection silk like membrane lines inner abdominal wall): 11 people, 61.11%
Drug Ineffective: 3 people, 16.67%
Death: 2 people, 11.11%
Upper Respiratory Tract Infection: 1 person, 5.56%
Dementia (madness): 1 person, 5.56%
Haematoma (collection of blood outside the blood vessels): 1 person, 5.56%
General Physical Health Deterioration (weak health status): 1 person, 5.56%
Fluid Overload (too much fluid in the blood): 1 person, 5.56%

What are the existing conditions these people have? *

Type 2 Diabetes: 12 people, 66.67%
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs): 2 people, 11.11%
Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 5.56%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.56%
Nausea (feeling of having an urge to vomit): 1 person, 5.56%
Multiple Myeloma (cancer of the plasma cells): 1 person, 5.56%
Hypotension (abnormally low blood pressure): 1 person, 5.56%
Hiv Infection: 1 person, 5.56%
Fungal Peritonitis (fungal infection silk like membrane lines inner abdominal wall): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Tazidime and have Colitis ischaemic?

- Check whether Colitis ischaemic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tazidime:

Tazidime (10,409 reports)

Browse all side effects of Tazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Colitis ischaemic:

Colitis ischaemic (800 drugs)

Browse all the conditions that are associated with Colitis ischaemic:

Colitis ischaemic (835 conditions)

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on ceftazidime (the active ingredients of Tazidime) and Tazidime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.